MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
62 hedge funds and large institutions have $56.5M invested in Mirati Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
98% less call options, than puts
Call options by funds: $2K | Put options by funds: $85K
Holders
62
Holding in Top 10
1
Calls
$2K
Puts
$85K
Top Buyers
| 1 | +$3.05M | |
| 2 | +$404K | |
| 3 | +$324K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$242K |
| 5 |
D.E. Shaw & Co
New York
|
+$186K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$1.08M | |
| 3 | -$827K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$826K |
| 5 |
Renaissance Technologies
New York
|
-$706K |